You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

sJIA

Showing 1 - 25 of 32
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset Trial in Japan (Anakinra, Placebo)

Recruiting
  • Still's Disease, Juvenile Onset
  • Still's Disease, Adult-Onset
  • Chiba-shi, Chiba, Japan
  • +17 more
Apr 3, 2023

Macrophage Activation Syndrome, Lymphohistiocytosis, Hemophagocytic, Arthritis, Juvenile Trial in Worldwide (Emapalumab)

Completed
Has Results
  • Macrophage Activation Syndrome
  • +3 more
  • Cincinnati, Ohio
  • +4 more
May 16, 2022

Juvenile Idiopathic Arthritis Trial in Worldwide (Sarilumab SAR153191 (REGN88))

Recruiting
  • Juvenile Idiopathic Arthritis
  • Sarilumab SAR153191 (REGN88)
  • Tucumán, Argentina
  • +29 more
Jan 9, 2023

Still's Disease, Adult-Onset, Still's Disease, Juvenile-Onset Trial in Canada, United States (anakinra, Placebo)

Terminated
Has Results
  • Still's Disease, Adult-Onset
  • Still's Disease, Juvenile-Onset
  • anakinra
  • Placebo
  • Birmingham, Alabama
  • +38 more
Jun 9, 2021

Juvenile Idiopathic Arthritis Trial (Upadacitinib, Tocilizumab)

Not yet recruiting
  • Juvenile Idiopathic Arthritis
  • (no location specified)
Nov 7, 2022

Genetics, and Pathophysiology of Systemic Juvenile Idiopathic

Recruiting
  • Still's Disease, Adult-Onset
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 18, 2022

    Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Baricitinib, Placebo)

    Recruiting
    • Systemic Juvenile Idiopathic Arthritis
    • Rosario, Santa Fe, Argentina
    • +65 more
    Jan 18, 2023

    Macrophage Activation Syndrome, Secondary Hemophagocytic Lymphohistiocytosis, Still Disease Trial in Worldwide (Emapalumab)

    Recruiting
    • Macrophage Activation Syndrome
    • +6 more
    • Birmingham, Alabama
    • +41 more
    Jan 3, 2023

    Juvenile Idiopathic Arthritis Trial in Worldwide (Tocilizumab)

    Completed
    • Juvenile Idiopathic Arthritis
    • Little Rock, Arkansas
    • +30 more
    Feb 22, 2022

    Kineret® in Systemic Juvenile Idiopathic Arthritis (SJIA)

    Completed
    • Still Disease, Juvenile Onset
    • Genova, Italy
      IRCCS Istituto G. Gaslini
    Nov 13, 2019

    Systemic Juvenile Idiopathic Arthritis Trial in Japan (Canakinumab)

    Completed
    Has Results
    • Systemic Juvenile Idiopathic Arthritis
    • Canakinumab
    • Obu, Aichi, Japan
    • +6 more
    Aug 7, 2019

    Juvenile Idiopathic Arthritis Trial in Worldwide (Tocilizumab)

    Completed
    • Juvenile Idiopathic Arthritis
    • Washington, District of Columbia
    • +19 more
    Oct 31, 2019

    Juvenile Idiopathic Arthritis Trial in Worldwide (Tocilizumab)

    Completed
    Has Results
    • Juvenile Idiopathic Arthritis
    • Los Angeles, California
    • +18 more
    Apr 9, 2020

    Juvenile Idiopathic Arthritis Trial in Worldwide (Tofacitinib)

    Recruiting
    • Juvenile Idiopathic Arthritis
    • Phoenix, Arizona
    • +134 more
    Jan 25, 2023

    Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

    Recruiting
    • Adamantinomatous Craniopharyngioma
    • Recurrent Adamantinomatous Craniopharyngioma
    • Aurora, Colorado
    • +17 more
    Jan 8, 2023

    Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Canakinumab)

    Completed
    Has Results
    • Systemic Juvenile Idiopathic Arthritis
    • Los Angeles, California
    • +72 more
    Mar 19, 2019

    Systemic Juvenile Idiopathic Arthritis (SJIA) Trial in Worldwide (ACZ885 150 mg (Canakinumab))

    Completed
    Has Results
    • Systemic Juvenile Idiopathic Arthritis (SJIA)
    • ACZ885 150 mg (Canakinumab)
    • Los Angeles, California
    • +49 more
    Jun 17, 2019

    COVID-19 Pnemonia Trial in Spain (Anakinra 149 MG/ML Prefilled Syringe [Kineret])

    Completed
    • COVID-19 Pnemonia
    • Anakinra 149 MG/ML Prefilled Syringe [Kineret]
    • Zaragoza, Aragón, Spain
    • +11 more
    May 27, 2021

    Clinical Characteristic and MEFV Gene Mutations in Juvenile

    Not yet recruiting
    • SLE (Systemic Lupus)
    • . MEFV genetic testing
    • (no location specified)
    Nov 20, 2020

    Schnitzler's Syndrome Trial in Berlin (Tocilizumab)

    Completed
    • Schnitzler's Syndrome
    • Berlin, Germay, Germany
      Charité - Universitätsmedizin Berlin, Dpt. of Dermatology and Al
    Feb 13, 2020

    Juvenile Idiopathic Arthritis Trial in Worldwide (CP-690,550 (tofacitinib), )

    Completed
    Has Results
    • Juvenile Idiopathic Arthritis
    • CP-690,550 (tofacitinib)
    • placebo
    • Little Rock, Arkansas
    • +102 more
    Mar 30, 2020

    Systemic Juvenile Idiopathic Arthritis Trial in Worldwide (Canakinumab, Placebo)

    Terminated
    Has Results
    • Systemic Juvenile Idiopathic Arthritis
    • Birmingham, Alabama
    • +90 more
    Feb 28, 2017

    Juvenile Idiopathic Arthritis Trial in Poland, Russian Federation (RoActemra/Actemra (tocilizumab))

    Terminated
    Has Results
    • Juvenile Idiopathic Arthritis
    • RoActemra/Actemra (tocilizumab)
    • Bydgoszcz, Poland
    • +10 more
    Aug 2, 2017

    Juvenile Idiopathic Arthritis Trial in Worldwide (Tocilizumab)

    Completed
    • Juvenile Idiopathic Arthritis
    • Little Rock, Arkansas
    • +41 more
    Nov 16, 2017

    Systemic Juvenile Idiopathic Arthritis Trial (ACZ885, Canakinumab)

    Withdrawn
    • Systemic Juvenile Idiopathic Arthritis
    • (no location specified)
    Oct 13, 2015